Bio-Rad Laboratories Class B
BIO.B
6 hedge funds and large institutions have $7.03M invested in Bio-Rad Laboratories Class B in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
20% more funds holding
Funds holding: 5 → 6 (+1)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.09% less ownership
Funds ownership: 0.7% → 0.61% (-0.09%)
13% less capital invested
Capital invested by funds: $8.11M → $7.03M (-$1.08M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$211K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$38.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$1.36M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $5.02M | – | – | – |
|
2
Dimensional Fund Advisors
Austin,
Texas
| $1.47M | – | – | – |
|
3
Renaissance Technologies
New York
| $251K | – | – | – |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $206K | +$211K | +930 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $82K | +$38.6K | +170 | +85% |
|
|
6
Bank of America
Charlotte,
North Carolina
| $1K | -$1.36M | -6,000 | -100% |
|
BIO.B Hedge Fund Activity: Q3 2017 in Review
6 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q3 2017, worth a combined $7.03M — down 13% from $8.11M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BIO.B positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $211K. The largest seller was Bank of America, cutting an estimated $1.36M.
- 6 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q3 2017, up from 5 in Q2 2017.
- Funds reported $7.03M of Bio-Rad Laboratories Class B stock for Q3 2017, down 13% quarter-over-quarter.
- 1 fund opened new Bio-Rad Laboratories Class B positions in Q3 2017 and 0 closed out, a net change of +1 holder.
- The largest Bio-Rad Laboratories Class B buyer in Q3 2017 was Susquehanna International Group, an estimated $211K added.
- The largest Bio-Rad Laboratories Class B seller in Q3 2017 was Bank of America, an estimated $1.36M sold.
Based on aggregated 13F filings for Q3 2017.